Skip to main content
# Title Department Research Year
41 Combined experimental/computational aspects for the molecular interaction of empagliflozin with bovine serum albumin: Quantification and application to human plasma Department of Medicinal Chemistry 2023
42 Design, synthesis and antiproliferative evaluation of lipidated 1, 3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors‏ Department of Pharmaceutical Organic Chemistry 2023
43 Impact of the functional coating of silver nanoparticles on their in vivo performance and biosafety Department of Industrial Pharmacy 2023
44 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
45 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
46 Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2023
47 Synthesis and characterization of magnetic Ag–Fe3O4@polymer hybrid nanocomposite systems with promising antibacterial application Department of Industrial Pharmacy 2023
48 Thiadiazine-2-thione Derivatives as New Carrier Systems for Isothiocyanates and Dithiocarbamic acid with Potential Anticancer Activities Department of Medicinal Chemistry 2023
49 Bifunctional Fe(III) metal-organic framework: A highly sensitive “turn-off” fluorescent probe and a precursor of magnetite nanoparticles for potential water decontamination Department of Pharmaceutical Analytical Chemistry 2023
50 A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study Department of Pharmaceutical Analytical Chemistry 2023